Health Plan Economics Masterclass

Banner for Masterclass Precon

 

 

Monday, Oct. 26 | 1-5:30pm, reception to follow 

$525 member, $625 non-member fee

Overview
Pharmaceutical market access professionals are expected to navigate increasingly complex payer environments—but often lack a clear understanding of how health plans evaluate financial risk, design benefits, and make coverage decisions.

This 4-hour interactive Masterclass provides a practical, payer-informed view of health plan economics across Commercial, Medicare, and Medicaid lines of business. Through a combination of actuarial insights, executive perspectives, and real-world examples, participants will gain a clearer understanding of the financial, operational, and strategic factors that shape access decisions.

Faculty
Christina Barrington, PharmD
Senior Vice President & Chief Pharmacy Officer
UPMC Health Plan

Jim Davidson, PharmD., MBA
Senior Pharmacy Consultant
Milliman

Estay Greene, PharmD, MBA
Vice President, Pharmacy Management
BlueCross BlueShield of South Carolina

Sudhakar Natarajan, FSA, MAAA
Senior Director
Optum Advisory Services

Carly Rodriguez, PharmD, FAMCP
Vice President & Chief Pharmacy Officer
Moda Health

Greg Warren FSA, FCA, MAAA
Partner and Consulting Actuary
Axene Health Partners, LLC

Agenda

1-1:15pm Welcome Remarks 
1:15-2pm 

Foundations: The Economics Behind Coverage
This opening session frames the core economic concepts that shape health plan decision-making across commercial, Medicare, and Medicaid markets. Faculty will introduce how premium dollars, rate dollars, risk, trend, reserves, and launch timing influence plan strategy and financial sustainability.

The session will close with a faculty exchange on the key differences across lines of business: commercial plans price the risk, Medicare plans bid against the benchmark, and Medicaid plans receive the rate.

2-2:45pm 

Commercial Deep Dive: From Actuarial Pressures to Pharmacy Strategy
This session examines how commercial market economics influence benefit design, employer and broker expectations, stop-loss considerations, and how new high-cost therapies are absorbed into future rates.

The discussion will connect actuarial pressures to pharmacy leadership decisions, including formulary tiering, prior authorization criteria, rebate strategy, and site-of-care management.  

2:45-3pm Networking Break 
3-3:45pm 

Medicare Deep Dive: Bids, Benchmarks, Stars, and Part D Redesign
This session explores the economic drivers shaping Medicare Advantage and Medicare Part D, including MA bids, benchmarks, CMS rebates, Star Ratings economics, and the impact of Part D redesign under the Inflation Reduction Act.

Faculty will discuss how these dynamics influence MA-PD formulary decisions and how policy changes are affecting plan behavior in real time.  

3:45-4:30pm 

Medicaid Deep Dive: Rate Setting, Risk, Rebates, and Managed Care Strategy
This session focuses on the Medicaid landscape, including capitation rate-setting, actuarial soundness, medical loss ratio floors, risk corridors, federal and supplemental rebates, and the relationship between state plan and managed care organization responsibilities.

Faculty will also discuss what is driving Medicaid pharmacy trend, mitigation strategies across fee-for-service and managed care environments, and future areas of Medicaid policy focus.  

4:30-4:45pm Networking Break 
4:45-5:15pm 

Open Panel: Ask Us Anything: The Health Plan Economics Hot Seat
The program concludes with a moderated discussion featuring all faculty. This interactive panel will compare how commercial, Medicare, and Medicaid plans respond differently to economic pressures, policy changes, high-cost therapies, and evolving market expectations.

Participants will have the opportunity to ask cross-line-of-business questions and explore how lessons from one market segment may inform thinking in another. 

5:15-5:30pm Closing Remarks 
5:30-6:30pm Networking Reception 

Why you should attend

  • Actuary-led instruction across all major lines of business
    Participants will hear directly from actuaries responsible for pricing, forecasting, and risk management in Commercial, Medicare, and Medicaid plans—bringing transparency to how financial decisions are modeled and evaluated.
  • Integrated payer leadership perspective
    Pharmacy and medical executives will provide context on how actuarial insights translate into decisions on formulary management, utilization management, and broader coverage strategy. (e.g., how tools like prior authorization, rebates, and benefit design influence cost and access decisions) 
  • Cross-functional view of the health plan enterprise
    The program highlights how actuarial teams interact with pharmacy, clinical, finance, and product functions to shape benefit design and access pathways.